RBP1 and neoplasm: Similar results have been described for CRBP1 in oesophageal squamous cell carcinoma (ESCC), as its promoter methylation was observed exclusively in advanced-stage tumours and was significantly associated with reduced mRNA expression, suggesting that epigenetic silencing of CRBP1 may contribute to tumour progression in ESCC.